Abstract
The World Health Organization recommends artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated falciparum malaria in the second and third trimesters of pregnancy. We conducted a meta-analysis to compare efficacy, safety and tolerability of ACTs versus quinine and other non-ACT antimalarials. The median PCR-adjusted failure rate by days 28 to 63 in the non-ACT group was 6 (range 0-37) per 100 women, lower in the ACT group overall (pooled risk ratio [PRR] random effects, 0.41; 95% confidence interval [CI], 0.16-1.05; 6 trials), and significantly lower compared with oral quinine (PRR, 0.20; 95% CI, 0.08-0.49; 4 trials). There were no differences in fetal deaths and congenital abnormalities. Compared with quinine, artemisinin-based combinations therapies were associated with less tinnitus (PRR, 0.19; 95% CI, 0.03-1.11; 4 studies), dizziness (PRR, 0.64; 95% CI, 0.44-0.93; 3 trials), and vomiting (PRR, 0.33; 95% CI, 0.15-0.73; 3 trials). Artemisinin-based combination therapies are better than quinine in the second and third trimesters; their use should be encouraged among health workers.
References
Feb 24, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·R McGreadyF Nosten
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A SowunmiA O Arowojolu
Aug 10, 2005·The Journal of Infectious Diseases·Rose McGreadyFrançois Nosten
Mar 24, 2006·Tropical Medicine & International Health : TM & IH·J-A MulliganA Mills
Jun 30, 2006·Contemporary Clinical Trials·Rebecca DerSimonian, Raghu Kacker
Jul 15, 2006·Trends in Parasitology·Huynh V ThienHans P Sauerwein
Jan 26, 2007·The Lancet Infectious Diseases·Meghna DesaiRobert D Newman
Feb 16, 2007·Malaria Journal·Stephanie DellicourBrian Greenwood
Nov 15, 2007·PloS One·Linda KalilaniSteven R Meshnick
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Monika Lutters, Nicole B Vogt-Ferrier
Mar 7, 2009·PLoS Medicine·Rose McGreadyFrançois Nosten
Apr 9, 2009·PloS One·Theonest K MutabingwaChristopher J M Whitty
Jul 22, 2009·PLoS Medicine·Alessandro LiberatiDavid Moher
Jan 1, 2008·Journal of Infection in Developing Countries·Daniel Kabonge KayeGrace Ndeezi
Dec 8, 2009·International Journal of Cardiology·Katrina K PoppeUNKNOWN MeRGE collaborators
Oct 12, 2010·The Lancet Infectious Diseases·Patrice PiolaPhilippe J Guerin
Jan 5, 2011·Journal of Clinical Epidemiology·Gordon GuyattHolger J Schünemann
Sep 3, 2011·PloS One·Lucy Smith PaintainJayne Webster
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
May 5, 2012·Malaria Journal·Atis MuehlenbachsPatrice Piola
Sep 18, 2012·Bulletin of the World Health Organization·Zebedee MwandiReinhard Kaiser
Nov 1, 2012·Malaria Journal·Anna M van EijkFeiko O Ter Kuile
Aug 6, 2014·PLoS Medicine·Jenny HillJayne Webster
Citations
Aug 6, 2014·PLoS Medicine·Jenny HillJayne Webster
May 16, 2013·PloS One·Fredrick L EyaseJacob D Johnson
Jul 3, 2016·Malaria Journal·Joaquín Pousibet-PuertoM Teresa Cabezas-Fernández
Aug 11, 2016·Reproductive Toxicology·Caroline GomesPaulo Roberto Dalsenter
Mar 19, 2014·Pharmacology & Therapeutics·Michael J ParnhamRobin Vos
Apr 13, 2018·MMWR. Morbidity and Mortality Weekly Report·Sarah-Blythe BallardKathrine R Tan
Dec 15, 2017·Malaria Journal·Makoto SaitoPhilippe J Guérin
Jul 12, 2017·Malaria Journal·Stephanie D KovacsAndy Stergachis
May 4, 2017·PLoS Medicine·Stephanie DellicourAndy Stergachis
Apr 10, 2020·Malaria Journal·Orvalho AugustoEsperança Sevene
Jan 25, 2021·Malaria Journal·Khalid A J Al Khaja, Reginald P Sequeira
Feb 6, 2018·The Lancet Infectious Diseases·Umberto D'AlessandroEsperanca Sevene
Sep 1, 2021·Malaria Journal·Fatoumata O MaigaJeffrey G Shaffer